Current infection detection methods often require invasive procedures like blood tests or swabs, and typically only identify infections after symptoms appear. This reactive approach leads to worse health outcomes and higher treatment costs. There's an opportunity to develop continuous, non-invasive monitoring that could detect infections earlier without disrupting daily life.
One approach could involve wearable devices that detect volatile organic compounds (VOCs) emitted through skin and breath - a field called volatolomics. These devices might:
The technology could be implemented as a standalone wearable, an add-on for existing smartwatches, or even a smartphone attachment for periodic breath analysis. Early versions might focus on detecting just 1-2 common infections with clear biomarkers, like influenza.
Such a system could help several groups:
Unlike existing wellness wearables that track general metrics like temperature, this would specifically target infection markers. And compared to one-time lab tests, it would provide continuous monitoring rather than snapshots.
An initial version might start as a smartphone attachment for breath analysis, focusing on a limited set of infections. This simpler approach could help validate the core technology before expanding to more complex continuous monitoring. Key challenges would include ensuring sensor accuracy in real-world conditions and addressing privacy concerns around health data collection.
While VOC-based detection currently has lower accuracy than lab tests, it could serve as an early warning system that prompts users to seek confirmatory testing. The value lies in catching infections earlier than waiting for symptoms, potentially preventing severe illness through timely intervention.
Hours To Execute (basic)
Hours to Execute (full)
Estd No of Collaborators
Financial Potential
Impact Breadth
Impact Depth
Impact Positivity
Impact Duration
Uniqueness
Implementability
Plausibility
Replicability
Market Timing
Project Type
Research